Table 3.

Characteristics of patients with observed cure and probability of cure estimated from the semiparametric mixture cure model.

	All Patients	Observed Cure*		Probability of Cure Ɨ
	Total	Number	% of Patients	%
	1211	250	20.6%	-
Synchronous	491	96	19.6%	22.5%
Metachronous	720	154	21.4%	27.8%
Node-Positive Primary	727	121	16.6%	21.4%
N1	466	82	17.6%	21.1%
N2	261	39	14.9%	20.3%
Node-Negative Primary	473	128	27.1%	30.0%
Preoperative CEA >200	119	11	9.2%	11.4%
Preoperative CEA ≤200	936	217	23.2%	25.7%
DFI <12 months	637	121	19.0%	23.4%
DFI ≥12 months	574	129	22.5%	24.9%
No. of hepatic tumors
Median	2	1
1	588	134	22.8%	24.3%
2 to 4	477	100	21.0%	25.8%
5 to 10	115	15	13.0%	15.1%
>10	31	1	3.2%	11.7%
Largest Hepatic Tumor >5cm	399	58	14.5%	18.6%
Largest Hepatic Tumor ≤5cm	812	192	23.6%	26.7%
Largest tumor, median cm	4.0cm	3.25cm
Extrahepatic Disease	88	7	8.0%	10.4%
No Extrahepatic Disease	1123	243	21.6%	25.2%
Fong Score
<2	627	165	26.3%	27.2%
≥3	420	63	15.0%	17.7%
Resection ≥3 segments	771	145	18.8%	25.2%
Perioperative HAIP	348	105	30.2%	29.5%
No Perioperative HAIP	863	145	16.8%	21.3%
Perioperative Chemo	1120	234	20.9%	24.6%
No Perioperative Chemo	91	16	17.6%	23.0%
Margin positive	109	9	8.3%	8.0%
Margin negative	1102	241	21.9%	27.2%

Note:

^*Observed Cure defined as 10-year survival with either no recurrence or resected recurrence with at least 3 years of disease-free follow-up,

^ƗProbability of cure was estimated from semiparametric mixture cure models